2018-2023 Global RNA-Based Therapeutics and Vaccines Market Report (Status and Outlook)

October 2018 | 137 pages | ID: 2DB365669A3EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global RNA-Based Therapeutics and Vaccines market for 2018-2023.
RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.
RNA-based biopharmaceuticals are a relatively new class of therapies that are demonstrating significant growth and potential for the treatment and prevention of chronic and rare diseases.

Over the next five years, LPI(LP Information) projects that RNA-Based Therapeutics and Vaccines will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of RNA-Based Therapeutics and Vaccines market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• RNA-Based Therapeutics
• RNA-Based Vaccines

Segmentation by application:

• Oncology
• Immunology
• Ophthalmology
• Cardiovascular Diseases
• Infectious Diseases
• Genetic Diseases
• Others

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Alnylam Pharmaceuticals
• Arbutus Biopharma
• Arrowhead Pharmaceuticals
• BioNTech
• CureVac
• Dicerna Pharmaceuticals
• Regulus Therapeutics
• Marina Biotech
• MiRagen Therapeutics
• Moderna Therapeutics
• Quark Pharmaceuticals
• Roche
• Sylentis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global RNA-Based Therapeutics and Vaccines market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of RNA-Based Therapeutics and Vaccines market by identifying its various subsegments.
• Focuses on the key global RNA-Based Therapeutics and Vaccines players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the RNA-Based Therapeutics and Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of RNA-Based Therapeutics and Vaccines submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET REPORT (STATUS AND OUTLOOK)

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global RNA-Based Therapeutics and Vaccines Market Size 2013-2023
  2.1.2 RNA-Based Therapeutics and Vaccines Market Size CAGR by Region
2.2 RNA-Based Therapeutics and Vaccines Segment by Type
  2.2.1 RNA-Based Therapeutics
  2.2.2 RNA-Based Vaccines
2.3 RNA-Based Therapeutics and Vaccines Market Size by Type
  2.3.1 Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2013-2018)
  2.3.2 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type (2013-2018)
2.4 RNA-Based Therapeutics and Vaccines Segment by Application
  2.4.1 Oncology
  2.4.2 Immunology
  2.4.3 Ophthalmology
  2.4.4 Cardiovascular Diseases
  2.4.5 Infectious Diseases
  2.4.6 Genetic Diseases
  2.4.7 Others
2.5 RNA-Based Therapeutics and Vaccines Market Size by Application
  2.5.1 Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2013-2018)
  2.5.2 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Application (2013-2018)

3 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES BY PLAYERS

3.1 Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Players
  3.1.1 Global RNA-Based Therapeutics and Vaccines Market Size by Players (2016-2018)
  3.1.2 Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Players (2016-2018)
3.2 Global RNA-Based Therapeutics and Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RNA-BASED THERAPEUTICS AND VACCINES BY REGIONS

4.1 RNA-Based Therapeutics and Vaccines Market Size by Regions
4.2 Americas RNA-Based Therapeutics and Vaccines Market Size Growth
4.3 APAC RNA-Based Therapeutics and Vaccines Market Size Growth
4.4 Europe RNA-Based Therapeutics and Vaccines Market Size Growth
4.5 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Growth

5 AMERICAS

5.1 Americas RNA-Based Therapeutics and Vaccines Market Size by Countries
5.2 Americas RNA-Based Therapeutics and Vaccines Market Size by Type
5.3 Americas RNA-Based Therapeutics and Vaccines Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC RNA-Based Therapeutics and Vaccines Market Size by Countries
6.2 APAC RNA-Based Therapeutics and Vaccines Market Size by Type
6.3 APAC RNA-Based Therapeutics and Vaccines Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe RNA-Based Therapeutics and Vaccines by Countries
7.2 Europe RNA-Based Therapeutics and Vaccines Market Size by Type
7.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa RNA-Based Therapeutics and Vaccines by Countries
8.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type
8.3 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET FORECAST

10.1 Global RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2023)
10.2 Global RNA-Based Therapeutics and Vaccines Forecast by Regions
  10.2.1 Global RNA-Based Therapeutics and Vaccines Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global RNA-Based Therapeutics and Vaccines Forecast by Type
10.8 Global RNA-Based Therapeutics and Vaccines Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Alnylam Pharmaceuticals
  11.1.1 Company Details
  11.1.2 RNA-Based Therapeutics and Vaccines Product Offered
  11.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Alnylam Pharmaceuticals News
11.2 Arbutus Biopharma
  11.2.1 Company Details
  11.2.2 RNA-Based Therapeutics and Vaccines Product Offered
  11.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Arbutus Biopharma News
11.3 Arrowhead Pharmaceuticals
  11.3.1 Company Details
  11.3.2 RNA-Based Therapeutics and Vaccines Product Offered
  11.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Arrowhead Pharmaceuticals News
11.4 BioNTech
  11.4.1 Company Details
  11.4.2 RNA-Based Therapeutics and Vaccines Product Offered
  11.4.3 BioNTech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 BioNTech News
11.5 CureVac
  11.5.1 Company Details
  11.5.2 RNA-Based Therapeutics and Vaccines Product Offered
  11.5.3 CureVac RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 CureVac News
11.6 Dicerna Pharmaceuticals
  11.6.1 Company Details
  11.6.2 RNA-Based Therapeutics and Vaccines Product Offered
  11.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Dicerna Pharmaceuticals News
11.7 Regulus Therapeutics
  11.7.1 Company Details
  11.7.2 RNA-Based Therapeutics and Vaccines Product Offered
  11.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Regulus Therapeutics News
11.8 Marina Biotech
  11.8.1 Company Details
  11.8.2 RNA-Based Therapeutics and Vaccines Product Offered
  11.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Marina Biotech News
11.9 MiRagen Therapeutics
  11.9.1 Company Details
  11.9.2 RNA-Based Therapeutics and Vaccines Product Offered
  11.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 MiRagen Therapeutics News
11.10 Moderna Therapeutics
  11.10.1 Company Details
  11.10.2 RNA-Based Therapeutics and Vaccines Product Offered
  11.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Moderna Therapeutics News
11.11 Quark Pharmaceuticals
11.12 Roche
11.13 Sylentis

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of RNA-Based Therapeutics and Vaccines
Figure RNA-Based Therapeutics and Vaccines Report Years Considered
Figure Market Research Methodology
Figure Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate 2013-2023 ($ Millions)
Table RNA-Based Therapeutics and Vaccines Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of RNA-Based Therapeutics
Table Major Players of RNA-Based Vaccines
Table Market Size by Type (2013-2018) ($ Millions)
Table Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2013-2018)
Figure Global RNA-Based Therapeutics Market Size Growth Rate
Figure Global RNA-Based Vaccines Market Size Growth Rate
Figure RNA-Based Therapeutics and Vaccines Consumed in Oncology
Figure Global RNA-Based Therapeutics and Vaccines Market: Oncology (2013-2018) ($ Millions)
Figure Global Oncology YoY Growth ($ Millions)
Figure RNA-Based Therapeutics and Vaccines Consumed in Immunology
Figure Global RNA-Based Therapeutics and Vaccines Market: Immunology (2013-2018) ($ Millions)
Figure Global Immunology YoY Growth ($ Millions)
Figure RNA-Based Therapeutics and Vaccines Consumed in Ophthalmology
Figure Global RNA-Based Therapeutics and Vaccines Market: Ophthalmology (2013-2018) ($ Millions)
Figure Global Ophthalmology YoY Growth ($ Millions)
Figure RNA-Based Therapeutics and Vaccines Consumed in Cardiovascular Diseases
Figure Global RNA-Based Therapeutics and Vaccines Market: Cardiovascular Diseases (2013-2018) ($ Millions)
Figure Global Cardiovascular Diseases YoY Growth ($ Millions)
Figure RNA-Based Therapeutics and Vaccines Consumed in Infectious Diseases
Figure Global RNA-Based Therapeutics and Vaccines Market: Infectious Diseases (2013-2018) ($ Millions)
Figure Global Infectious Diseases YoY Growth ($ Millions)
Table Global RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) ($ Millions)
Table Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Market Size in Oncology Growth Rate
Figure Global RNA-Based Therapeutics and Vaccines Market Size in Immunology Growth Rate
Figure Global RNA-Based Therapeutics and Vaccines Market Size in Ophthalmology Growth Rate
Figure Global RNA-Based Therapeutics and Vaccines Market Size in Cardiovascular Diseases Growth Rate
Figure Global RNA-Based Therapeutics and Vaccines Market Size in Infectious Diseases Growth Rate
Figure Global RNA-Based Therapeutics and Vaccines Market Size in Genetic Diseases Growth Rate
Figure Global RNA-Based Therapeutics and Vaccines Market Size in Others Growth Rate
Table Global RNA-Based Therapeutics and Vaccines Revenue by Players (2016-2018) ($ Millions)
Table Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players (2016-2018)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players in 2017
Table Global RNA-Based Therapeutics and Vaccines Key Players Head office and Products Offered
Table RNA-Based Therapeutics and Vaccines Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global RNA-Based Therapeutics and Vaccines Market Size by Regions 2013-2018 ($ Millions)
Table Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Regions 2013-2018
Figure Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Regions 2013-2018
Figure Americas RNA-Based Therapeutics and Vaccines Market Size 2013-2018 ($ Millions)
Figure APAC RNA-Based Therapeutics and Vaccines Market Size 2013-2018 ($ Millions)
Figure Europe RNA-Based Therapeutics and Vaccines Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size 2013-2018 ($ Millions)
Table Americas RNA-Based Therapeutics and Vaccines Market Size by Countries (2013-2018) ($ Millions)
Table Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Countries (2013-2018)
Figure Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Countries in 2017
Table Americas RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) ($ Millions)
Table Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2013-2018)
Figure Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Type in 2017
Table Americas RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) ($ Millions)
Table Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2013-2018)
Figure Americas RNA-Based Therapeutics and Vaccines Market Size Market Share by Application in 2017
Figure United States RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure Canada RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure Mexico RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Table APAC RNA-Based Therapeutics and Vaccines Market Size by Countries (2013-2018) ($ Millions)
Table APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Countries (2013-2018)
Figure APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Countries in 2017
Table APAC RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) ($ Millions)
Table APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2013-2018)
Figure APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Type in 2017
Table APAC RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) ($ Millions)
Table APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2013-2018)
Figure APAC RNA-Based Therapeutics and Vaccines Market Size Market Share by Application in 2017
Figure China RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure Japan RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure Korea RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure India RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure Australia RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Table Europe RNA-Based Therapeutics and Vaccines Market Size by Countries (2013-2018) ($ Millions)
Table Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Countries (2013-2018)
Figure Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Countries in 2017
Table Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) ($ Millions)
Table Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2013-2018)
Figure Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Type in 2017
Table Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) ($ Millions)
Table Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2013-2018)
Figure Europe RNA-Based Therapeutics and Vaccines Market Size Market Share by Application in 2017
Figure Germany RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure France RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure UK RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure Italy RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure Russia RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure Spain RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Countries in 2017
Table Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Type in 2017
Table Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size Market Share by Application in 2017
Figure Egypt RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure South Africa RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure Israel RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure Turkey RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries RNA-Based Therapeutics and Vaccines Market Size Growth 2013-2018 ($ Millions)
Figure Global RNA-Based Therapeutics and Vaccines arket Size Forecast (2018-2023) ($ Millions)
Table Global RNA-Based Therapeutics and Vaccines Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global RNA-Based Therapeutics and Vaccines Market Size Market Share Forecast by Regions
Figure Americas RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure APAC RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Europe RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure United States RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Canada RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Mexico RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Brazil RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure China RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Japan RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Korea RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure India RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Australia RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Germany RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure France RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure UK RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Italy RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Russia RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Spain RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Egypt RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure South Africa RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Israel RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure Turkey RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Figure GCC Countries RNA-Based Therapeutics and Vaccines Market Size 2018-2023 ($ Millions)
Table Global RNA-Based Therapeutics and Vaccines Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global RNA-Based Therapeutics and Vaccines Market Size Market Share Forecast by Type (2018-2023)
Table Global RNA-Based Therapeutics and Vaccines Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global RNA-Based Therapeutics and Vaccines Market Size Market Share Forecast by Application (2018-2023)
Table Alnylam Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue and Gross Margin (2016-2018)
Figure Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Market Share (2016-2018)
Table Arbutus Biopharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue and Gross Margin (2016-2018)
Figure Arbutus Biopharma RNA-Based Therapeutics and Vaccines Market Share (2016-2018)
Table Arrowhead Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue and Gross Margin (2016-2018)
Figure Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Market Share (2016-2018)
Table BioNTech Basic Information, Head Office, Major Market Areas and Its Competitors
Table BioNTech RNA-Based Therapeutics and Vaccines Revenue and Gross Margin (2016-2018)
Figure BioNTech RNA-Based Therapeutics and Vaccines Market Share (2016-2018)
Table CureVac Basic Information, Head Office, Major Market Areas and Its Competitors
Table CureVac RNA-Based Therapeutics and Vaccines Revenue and Gross Margin (2016-2018)
Figure CureVac RNA-Based Therapeutics and Vaccines Market Share (2016-2018)
Table Dicerna Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue and Gross Margin (2016-2018)
Figure Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Market Share (2016-2018)
Table Regulus Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue and Gross Margin (2016-2018)
Figure Regulus Therapeutics RNA-Based Therapeutics and Vaccines Market Share (2016-2018)
Table Marina Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table Marina Biotech RNA-Based Therapeutics and Vaccines Revenue and Gross Margin (2016-2018)
Figure Marina Biotech RNA-Based Therapeutics and Vaccines Market Share (2016-2018)
Table MiRagen Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue and Gross Margin (2016-2018)
Figure MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Market Share (2016-2018)
Table Moderna Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue and Gross Margin (2016-2018)
Figure Moderna Therapeutics RNA-Based Therapeutics and Vaccines Market Share (2016-2018)
Table Quark Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sylentis Basic Information, Head Office, Major Market Areas and Its Competitors